Who are Aspirin, Acetaminophen, Caffeine pills's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/aspirin-acetaminophen-caffeine-pills.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Aspirin, Acetaminophen, Caffeine pills — Competitive Intelligence Brief

Aspirin, Acetaminophen, Caffeine pills (Aspirin, Acetaminophen, Caffeine pills) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Analgesic combination product. Area: Pain Management.

marketed Analgesic combination product Cyclooxygenase (COX-1, COX-2); adenosine receptors (caffeine) Pain Management Small molecule Live · refreshed every 30 min

Target snapshot

Aspirin, Acetaminophen, Caffeine pills (Aspirin, Acetaminophen, Caffeine pills) — Albert Einstein Healthcare Network. This combination product reduces pain and fever through cyclooxygenase inhibition (aspirin and acetaminophen) while caffeine enhances analgesic efficacy and provides mild stimulation.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Aspirin, Acetaminophen, Caffeine pills TARGET	Aspirin, Acetaminophen, Caffeine pills	Albert Einstein Healthcare Network	marketed	Analgesic combination product	Cyclooxygenase (COX-1, COX-2); adenosine receptors (caffeine)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Analgesic combination product class)

Albert Einstein Healthcare Network · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Aspirin, Acetaminophen, Caffeine pills — Competitive Intelligence Brief. https://druglandscape.com/ci/aspirin-acetaminophen-caffeine-pills. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab